-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
International Stem Cell CORP quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- International Stem Cell CORP Operating Income (Loss) for the quarter ending September 30, 2024 was -$90K, a 7.22% increase year-over-year.
- International Stem Cell CORP Operating Income (Loss) for the twelve months ending September 30, 2024 was -$543K, a 205% decline year-over-year.
- International Stem Cell CORP annual Operating Income (Loss) for 2023 was -$663K, a 262% decline from 2022.
- International Stem Cell CORP annual Operating Income (Loss) for 2022 was -$183K, a 90.5% increase from 2021.
- International Stem Cell CORP annual Operating Income (Loss) for 2021 was -$1.92M, a 31.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)